Geraci Je
Impact in
- Microbiology top 5%
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Diphtheria, Corynebacterium, and Tetanus 9
- Journals
- PubMed (36 papers)
In The Last Decade
Geraci Je
34 papers receiving 482 citations
Peers
Comparison fields: 5 of 82
- Microbiology 23
- Clinical Biochemistry 116
- Infectious Diseases 308
- Endocrinology 57
- Epidemiology 343
Countries citing papers authored by Geraci Je
This map shows the geographic impact of Geraci Je's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geraci Je with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geraci Je more than expected).
Fields of papers citing papers by Geraci Je
This network shows the impact of papers produced by Geraci Je. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geraci Je. The network helps show where Geraci Je may publish in the future.
Co-authorship network
The 17 scholars most cited alongside Geraci Je, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The current status of erythromycin, kanamycin, novobiocin, oleandomycin, ristocetin, and vancomycin, with particular reference to their use in staphylococcal disease; panel discussion. | 2000 | 2 |
| 2 | Treatment of penicillin-sensitive streptococcal infective endocarditis. | 1982 | 19 |
| 3 | General considerations in the diagnosis and treatment of infective endocarditis. | 1982 | 17 |
| 4 | Eikenella corrodens endocarditis: report of cure in two cases. | 1974 | 31 |
| 5 | Endocarditis due to a rapidly growing chromogenic Mycobacterium. | 1968 | 25 |
| 6 | Methicillin and other semisynthetic penicillins in the therapy of staphylococcal endocarditis. | 1965 | 1 |
| 7 | DISSEMINATED HISTOPLASMOSIS PRESENTING AS A BRAIN TUMOR AND TREATED WITH AMPHOTERICIN. B. REPORT OF CASE. | 1964 | 10 |
| 8 | Bacterial endocarditis and endarteritis following cardiac operations. | 1963 | 61 |
| 9 | Novobiocin (streptonivicin, cathomycin): further observations. | 1956 | 3 |
| 10 | Laboratory studies of oleandomycin (matromycin). | 1956 | 4 |
| 11 | Further experiences with short-term (2 weeks) combined penicillinstreptomycin therapy for bacterial endocarditis caused by penicillin-sensitive streptococci. | 1955 | 15 |
| 12 | Toxic-organic psychosis as a presenting feature in bacterial endocarditis. | 1955 | 9 |
| 13 | Bacteremia owing to Pseudomonas aeruginosa: review of 10 cases. | 1954 | 12 |
| 14 | General principles and use of antibiotics. | 1954 | 7 |
| 15 | Antibiotic therapy of bacterial endocarditis. V. Therapeutic considerations of erythromycin. | 1954 | 11 |
| 16 | Micrococcal (staphylococcal) enterocolitis: therapeutic considerations. | 1954 | 2 |
| 17 | Antibiotic therapy in bacterial endocarditis. III. Penicillin O and hypoallergenic penicillins in treatment of subacute bacterial endocarditis. | 1953 | 3 |
| 18 | Infarction of the greater omentum simulating acute cholecystitis; report of case. | 1953 | 2 |
| 19 | Antibiotic therapy of bacterial endocarditis. II. Current trends in the treatment of subacute bacterial endocarditis. | 1952 | 8 |
| 20 | Cardiac clinics. CXXXVIII. Bacterial endocarditis of the tricuspid valve in a 15-month-old infant. | 1952 | 2 |
About Geraci Je
Geraci Je is a scholar working on Microbiology, Endocrinology, Clinical Biochemistry, Epidemiology and Infectious Diseases, having authored 36 papers that have together received 661 indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (18 papers), Diphtheria, Corynebacterium, and Tetanus (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (7 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Cardiac Valve Diseases and Treatments (2 papers), Drug-Induced Adverse Reactions (2 papers) and Probiotics and Fermented Foods (2 papers). The work is most often cited by research in Microbiology (23 citations), Clinical Biochemistry (116 citations), Infectious Diseases (308 citations), Endocrinology (57 citations) and Epidemiology (343 citations). Frequent co-authors include Heilman Fr, Nichols Dr, Wilson Wr, Danielson Gk, McGoon Dc, Washington Ja, Martin Wj, Ellis Fh, Miller Rh and Jack P. Antel. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.